| pubmed-article:21709196 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21709196 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21709196 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:21709196 | lifeskim:mentions | umls-concept:C0017636 | lld:lifeskim |
| pubmed-article:21709196 | lifeskim:mentions | umls-concept:C0076080 | lld:lifeskim |
| pubmed-article:21709196 | lifeskim:mentions | umls-concept:C1831741 | lld:lifeskim |
| pubmed-article:21709196 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:21709196 | lifeskim:mentions | umls-concept:C1518321 | lld:lifeskim |
| pubmed-article:21709196 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:21709196 | pubmed:dateCreated | 2011-7-29 | lld:pubmed |
| pubmed-article:21709196 | pubmed:abstractText | The management of glioblastoma multiforme (GBM) in elderly patients with poor performance status is not well established. A trial evaluating the efficacy and safety of temozolomide alone in this population was undertaken. | lld:pubmed |
| pubmed-article:21709196 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21709196 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21709196 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21709196 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21709196 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21709196 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21709196 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21709196 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21709196 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21709196 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21709196 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21709196 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:21709196 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:HonnoratJérôm... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:DelattreJean-... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:ChinotOlivier... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:BeauchesnePat... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:GuillamoJean-... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:TanguyMarie-L... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:Cartalat-Care... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:MokhtariKarim... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:TaillandierLu... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:HuchetAymeriA | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:BarrieMarylin... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:Gállego... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:DucrayFrançoi... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:CampelloChant... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:MattaMonaM | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:MonjourAnnick... | lld:pubmed |
| pubmed-article:21709196 | pubmed:author | pubmed-author:Catry-ThomasI... | lld:pubmed |
| pubmed-article:21709196 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21709196 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:21709196 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:21709196 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21709196 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21709196 | pubmed:pagination | 3050-5 | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:meshHeading | pubmed-meshheading:21709196... | lld:pubmed |
| pubmed-article:21709196 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21709196 | pubmed:articleTitle | Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. | lld:pubmed |
| pubmed-article:21709196 | pubmed:affiliation | Service de Neurologie 2-Mazarin, Groupe Hospitalier Pitié-Salpêtrière, 47-83 Blvd de l'Hôpital, Paris, France. | lld:pubmed |
| pubmed-article:21709196 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21709196 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:21709196 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21709196 | lld:pubmed |
